Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 17 studies | 26% ± 10% | |
classical monocyte | 17 studies | 25% ± 9% | |
non-classical monocyte | 10 studies | 22% ± 7% | |
astrocyte | 8 studies | 35% ± 16% | |
monocyte | 7 studies | 20% ± 4% | |
myeloid cell | 6 studies | 23% ± 5% | |
neutrophil | 4 studies | 19% ± 0% | |
microglial cell | 4 studies | 28% ± 8% | |
mononuclear phagocyte | 3 studies | 20% ± 3% | |
endothelial cell | 3 studies | 21% ± 2% |
Insufficient scRNA-seq data for expression of TLR4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2945.73 | 458 / 459 | 88% | 5.84 | 988 / 1118 |
kidney | 98% | 1207.26 | 87 / 89 | 87% | 9.22 | 785 / 901 |
brain | 85% | 1013.98 | 2257 / 2642 | 98% | 17.41 | 692 / 705 |
lung | 100% | 2987.79 | 577 / 578 | 76% | 4.82 | 878 / 1155 |
thymus | 99% | 1479.16 | 647 / 653 | 74% | 2.96 | 448 / 605 |
adrenal gland | 100% | 1708.97 | 257 / 258 | 72% | 4.64 | 166 / 230 |
intestine | 93% | 908.95 | 898 / 966 | 77% | 6.15 | 407 / 527 |
bladder | 95% | 912.14 | 20 / 21 | 64% | 4.14 | 323 / 504 |
prostate | 93% | 943.03 | 227 / 245 | 66% | 3.05 | 331 / 502 |
skin | 80% | 1460.16 | 1453 / 1809 | 62% | 4.28 | 292 / 472 |
uterus | 96% | 933.66 | 163 / 170 | 37% | 1.56 | 169 / 459 |
stomach | 50% | 410.55 | 180 / 359 | 79% | 5.14 | 225 / 286 |
esophagus | 70% | 786.65 | 1016 / 1445 | 45% | 2.23 | 82 / 183 |
ovary | 77% | 786.94 | 139 / 180 | 37% | 1.42 | 159 / 430 |
adipose | 100% | 3796.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.51 | 29 / 29 |
spleen | 100% | 5629.05 | 241 / 241 | 0% | 0 | 0 / 0 |
liver | 58% | 429.26 | 132 / 226 | 36% | 1.44 | 148 / 406 |
heart | 94% | 959.59 | 808 / 861 | 0% | 0 | 0 / 0 |
pancreas | 10% | 62.29 | 33 / 328 | 83% | 4.79 | 147 / 178 |
blood vessel | 92% | 1491.68 | 1223 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 81% | 7802.68 | 750 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 65% | 3.70 | 52 / 80 |
tonsil | 0% | 0 | 0 / 0 | 49% | 2.12 | 22 / 45 |
muscle | 47% | 319.76 | 380 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007254 | Biological process | JNK cascade |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0070427 | Biological process | nucleotide-binding oligomerization domain containing 1 signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0032732 | Biological process | positive regulation of interleukin-1 production |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0006955 | Biological process | immune response |
GO_0042088 | Biological process | T-helper 1 type immune response |
GO_0070434 | Biological process | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO_0034142 | Biological process | toll-like receptor 4 signaling pathway |
GO_0006909 | Biological process | phagocytosis |
GO_0002730 | Biological process | regulation of dendritic cell cytokine production |
GO_1904466 | Biological process | positive regulation of matrix metallopeptidase secretion |
GO_0032689 | Biological process | negative regulation of type II interferon production |
GO_0014002 | Biological process | astrocyte development |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0035666 | Biological process | TRIF-dependent toll-like receptor signaling pathway |
GO_0045348 | Biological process | positive regulation of MHC class II biosynthetic process |
GO_0002537 | Biological process | nitric oxide production involved in inflammatory response |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0045087 | Biological process | innate immune response |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_1903428 | Biological process | positive regulation of reactive oxygen species biosynthetic process |
GO_0002322 | Biological process | B cell proliferation involved in immune response |
GO_0014911 | Biological process | positive regulation of smooth muscle cell migration |
GO_1900017 | Biological process | positive regulation of cytokine production involved in inflammatory response |
GO_0043032 | Biological process | positive regulation of macrophage activation |
GO_2000343 | Biological process | positive regulation of chemokine (C-X-C motif) ligand 2 production |
GO_0051403 | Biological process | stress-activated MAPK cascade |
GO_1903974 | Biological process | positive regulation of cellular response to macrophage colony-stimulating factor stimulus |
GO_0007252 | Biological process | I-kappaB phosphorylation |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0071223 | Biological process | cellular response to lipoteichoic acid |
GO_0006809 | Biological process | nitric oxide biosynthetic process |
GO_0045429 | Biological process | positive regulation of nitric oxide biosynthetic process |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0070430 | Biological process | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0070431 | Biological process | nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO_0010467 | Biological process | gene expression |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_0032700 | Biological process | negative regulation of interleukin-17 production |
GO_0060729 | Biological process | intestinal epithelial structure maintenance |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0036120 | Biological process | cellular response to platelet-derived growth factor stimulus |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0002755 | Biological process | MyD88-dependent toll-like receptor signaling pathway |
GO_0042116 | Biological process | macrophage activation |
GO_2001238 | Biological process | positive regulation of extrinsic apoptotic signaling pathway |
GO_0032874 | Biological process | positive regulation of stress-activated MAPK cascade |
GO_0051770 | Biological process | positive regulation of nitric-oxide synthase biosynthetic process |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0032727 | Biological process | positive regulation of interferon-alpha production |
GO_0043406 | Biological process | positive regulation of MAP kinase activity |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0030890 | Biological process | positive regulation of B cell proliferation |
GO_0060907 | Biological process | positive regulation of macrophage cytokine production |
GO_0010572 | Biological process | positive regulation of platelet activation |
GO_1904646 | Biological process | cellular response to amyloid-beta |
GO_0140052 | Biological process | cellular response to oxidised low-density lipoprotein particle stimulus |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0031663 | Biological process | lipopolysaccharide-mediated signaling pathway |
GO_0002224 | Biological process | toll-like receptor signaling pathway |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0032707 | Biological process | negative regulation of interleukin-23 production |
GO_0032735 | Biological process | positive regulation of interleukin-12 production |
GO_0045342 | Biological process | MHC class II biosynthetic process |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_1900227 | Biological process | positive regulation of NLRP3 inflammasome complex assembly |
GO_0016046 | Biological process | detection of fungus |
GO_0014004 | Biological process | microglia differentiation |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0042742 | Biological process | defense response to bacterium |
GO_0002246 | Biological process | wound healing involved in inflammatory response |
GO_0032729 | Biological process | positive regulation of type II interferon production |
GO_0032497 | Biological process | detection of lipopolysaccharide |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0045671 | Biological process | negative regulation of osteoclast differentiation |
GO_0009986 | Cellular component | cell surface |
GO_0010008 | Cellular component | endosome membrane |
GO_0001726 | Cellular component | ruffle |
GO_0046696 | Cellular component | lipopolysaccharide receptor complex |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005769 | Cellular component | early endosome |
GO_0001891 | Cellular component | phagocytic cup |
GO_0005737 | Cellular component | cytoplasm |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0001875 | Molecular function | lipopolysaccharide immune receptor activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0061809 | Molecular function | NAD+ nucleotidase, cyclic ADP-ribose generating |
GO_0001530 | Molecular function | lipopolysaccharide binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TLR4 |
Protein name | Toll like receptor 4 protein Toll-like receptor 4 (hToll) (CD antigen CD284) Toll like receptor 4 Toll-like receptor 4 |
Synonyms | TLR-4 |
Description | FUNCTION: Transmembrane receptor that functions as a pattern recognition receptor recognizing pathogen- and damage-associated molecular patterns (PAMPs and DAMPs) to induce innate immune responses via downstream signaling pathways . At the plasma membrane, cooperates with LY96 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) . Also involved in LPS-independent inflammatory responses triggered by free fatty acids, such as palmitate, and Ni(2+) . Mechanistically, acts via MYD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response . Alternatively, CD14-mediated TLR4 internalization via endocytosis is associated with the initiation of a MYD88-independent signaling via the TICAM1-TBK1-IRF3 axis leading to type I interferon production . In addition to the secretion of proinflammatory cytokines, initiates the activation of NLRP3 inflammasome and formation of a positive feedback loop between autophagy and NF-kappa-B signaling cascade . In complex with TLR6, promotes inflammation in monocytes/macrophages by associating with TLR6 and the receptor CD86 . Upon ligand binding, such as oxLDL or amyloid-beta 42, the TLR4:TLR6 complex is internalized and triggers inflammatory response, leading to NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway . In myeloid dendritic cells, vesicular stomatitis virus glycoprotein G but not LPS promotes the activation of IRF7, leading to type I IFN production in a CD14-dependent manner . Required for the migration-promoting effects of ZG16B/PAUF on pancreatic cancer cells. . |
Accessions | D2JYI4 D2JYI3 A0A2R8Y7P4 D2JYI6 ENST00000472304.2 D1CS55 A0A3Q8PZA0 D2JYI9 O00206 D2JYI2 D2JYI7 D2JYI5 A0A7D5XLN4 ENST00000355622.8 [O00206-1] ENST00000394487.5 [O00206-2] D2JYI8 |